Vitamin d receptor fok-i polymorphism modulates diabetic host response to Vitamin D Intake

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 550-556

  Neyestani, Tirang R ^a   Djazayery, Abolghassem ^b   Shab Bidar, Sakineh ^b   Eshraghian, Mohammad Reza ^b   Kalayi, Ali ^a   Shariatzadeh, Nastaran ^a   Khalaji, Niloufar ^a   Zahedirad, Malihe ^a   Gharavi, A'Zam ^b   Houshiarrad, Anahita ^a   Chamari, Maryam ^b   Asadzadeh, Sepideh ^a  

^a National Nutrition and Food Technology Research Institute Tehran   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; C REACTIVE PROTEIN; CALCIUM; ENDOTHELIN 1; FOK 1 PROTEIN; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 2; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; YOGHURT;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DNA DETERMINATION; DNA POLYMORPHISM; FAT MASS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUN EXPOSURE; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; VITAMIN INTAKE; WAIST CIRCUMFERENCE;

ADULT; AGED; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84874438572     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0919     Document Type: Article

References (40)

1. Winer N, Sowers Jr. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405
2. Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, et al. Is vitamin D status a determining factor for metabolic syndrome? A casecontrol study. DiabetesMetab SyndrObes 2011;2:205-211
3. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Regular consumption of vitamin Dfortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized doubleblind clinical trial. BMC Med 2011;9:125
4. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev 2012;28:424-430
5. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011;65:1005-1015
6. Palomer X, Gonz-alez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-197
7. Wang Q, Xi B, Reilly KH, Liu M, Fu M. Quantitative assessment of the associations between four polymorphisms (FokI, ApaI, BsmI, TaqI) of vitamin D receptor gene and risk of diabetes mellitus. Mol Biol Rep 2012;39:9405-9414
8. Bid HK, Konwar R, Aggarwal CG, et al. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 2009;63:187-194
9. MaleckiMT, Frey J, MoczulskiD, Klupa T, Kozek E, Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 2003;111:505-509
10. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001;2:2
11. Shab-Bidar S, Neyestani TR, Djazayery A. Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord 2011;11:12
12. Kalantari N, Ghafarpour, M. National Comprehensive Study on Household Food Consumption Pattern and Nutritional Status, IR Iran, 2001-2003. (National Report) 2005
13. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410
14. Neyestani TR, Gharavi A, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 2007;77:341-346
15. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute ofMedicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58
16. Neyestani TR, Gharavi A, Kalayi A. Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr 2009;60(Suppl. 1):79-88
17. Deng HW, Shen H, Xu FH, et al. Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 2002;17:678-686
18. Välimäki VV, Löyttyniemi E, VälimäkiMJ. Vitamin D fortification of milk products does not resolve hypovitaminosis D in young Finnish men. Eur J Clin Nutr 2007; 61:493-497
19. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-3661
20. McCullough ML, Bostick RM, Daniel CR, et al. Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr 2009;28:678-686
21. NelsonML, Blum JM,Hollis BW, Rosen C, Sullivan SS. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J Nutr 2009;139:540-546
22. Elnenaei MO, Chandra R, Mangion T, Moniz C. Genomic and metabolomic patterns segregate with responses to calciumand vitamin D supplementation. Br J Nutr 2011;105:71-79
23. Orton SM, Morris AP, Herrera BM, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008;88:441-447
24. Dimitriadou M, Christoforidis A, Fidani L, et al. Fok-I gene polymorphismof vitamin Dreceptor in patientswith beta-thalassemia major and its effect on vitamin D status. Hematology 2011;16:54-58
25. Zofkova I, Zajickova K, Hill M. Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women. Eur J Intern Med 2003;14:232-236
26. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004;89-90: 121-125
27. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 2001; 18:842-845
28. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002;51:356-359
29. Vélayoudom-Céphise FL, Larifla L, Donnet JP, et al. Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab 2011;37:540-545
30. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008;11:134-139
31. Al-Daghri NM, Al-Attas O, Alokail MS, et al. Vitamin D receptor gene polymorphisms and HLA DRB1.*04 cosegregation in Saudi type 2 diabetes patients. J Immunol 2012;188:1325-1332
32. Milicevic Z, Raz I, Beattie SD, et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008;31(Suppl. 2): S155-S160
33. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
34. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999;48:937-942
35. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27: 813-823
36. Pickup JC, Mattock MB. Activation of the innate immune system as a predictor of cardiovascular mortality in type 2 diabetes mellitus. Diabet Med 2003;20: 723-726
37. Neyestani TR, Nikooyeh B, Alavi-Majd H, et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab 2012;97:2005-2011
38. Nikooyeh B,Neyestani TR, FarvidM, et al. Daily consumption of vitamin D-or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. AmJ ClinNutr 2011;93:764-771
39. Alimirah F, Peng X, Murillo G, Mehta RG. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS ONE 2011;6: e16024
40. Berry DJ, Vimaleswaran KS, Whittaker JC, Hingorani AD, Hyppönen E. Evaluation of genetic markers as instruments for mendelian randomization studies on vitamin D. PLoS ONE 2012;7:e37465